Mechanistic studies are necessary to investigate how FGF19 interacts with other pathways, such as integrin signaling in glioblastoma multiforme, and its role in tumor progression, with the potential to reveal novel therapeutic targets and inform combination strategies. Here, FGF19 is linked to neoplasm.